GHR-2 (GHRP-2 Oral)

Also known as: Growth Hormone Releasing Peptide-2 Oral

Oral formulation of GHRP-2 designed for sublingual absorption; same ghrelin-mimetic GH secretagogue mechanism as injectable GHRP-2.

Typical dose: 100 mcg – 300 mcg
Frequency: twice daily
Route: Oral
Half-life: 15 minutes
Routes: Oral
Status: Research chemical

Track your GHR-2 (GHRP-2 Oral) protocol in Vial →

Benefits

GH release without injection
Appetite stimulation
Improved sleep quality
Sublingual convenience

Dosing

A common research range for GHR-2 (GHRP-2 Oral) is 100 mcg to 300 mcg twice daily. Sublingual; hold under tongue 60-90 seconds. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Half-life

GHR-2 (GHRP-2 Oral) has an approximate half-life of 15 minutes. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

Room temperature; keep dry.

Reported side effects

Increased appetite
Water retention
Tingling

Contraindications

Active cancer
Pituitary disorders

Commonly stacked with

CJC-1295 (no DAC)

Track GHR-2 (GHRP-2 Oral) with Vial

Vial logs every GHR-2 (GHRP-2 Oral) dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. GHR-2 (GHRP-2 Oral) is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.